Podcasts about Pharmaceutical industry

In this episode of the HVAC Know It All Podcast, host Gary McCreadie continues his discussion with John Ellis, a Product Ambassador at Dust Free, LP, an Instructor at Amana/Goodman/Dakin, and a Field Service Trainer at The New Flat Rate, Inc, on air quality, system design, and the role of UV lights in HVAC systems. In Part 02 of their talk, Gary and John explore the importance of air mixing, static pressure, and system performance. They break down how proper air distribution and good filtration can improve efficiency and comfort. They also dive into UV lamp use and its effectiveness in residential applications, offering practical insights for technicians on balancing technology with system design. John and Gary discuss the importance of air mixing in HVAC systems and how it affects air quality and comfort. They explain how poor air circulation can lead to stagnant pockets of air, causing pollutants to build up. John shares how using ceiling fans or proper system design can help improve air movement. They also talk about the impact of static pressure on airflow and how to balance it when designing systems. Finally, John gives his thoughts on UV lamps in HVAC systems, explaining why they can be useful but may not always be the best solution. This episode is packed with practical HVAC tips, air quality insights, and expert advice on system design. It helps techs understand the importance of air mixing, managing static pressure, and improving airflow. John and Gary also share their thoughts on UV lamps and how they can be useful in certain situations. This episode is all about using the right techniques to improve system efficiency and comfort while making informed decisions. Expect to Learn: The role of air mixing in improving HVAC comfort and air quality. How static pressure affects airflow and system performance. When UV lamps are useful and when they aren't ideal. The benefits of tight systems and good filtration for efficiency. Why system design should minimize the need for additional tech like UV lamps. Episode Highlights: [00:00] - Intro to John Ellis in Part 02 [01:40] - Importance of Ceiling Fans and Air Mixing in HVAC Design [05:26] - Real-World Experience in Pharmaceutical Industry [07:22] - Airflow vs. Static Pressure [09:46] - UV Lamps for Sanitizing Coils and Drain Pans [11:46] - Photocatalytic Oxidizers and the Dangers of Byproducts [16:05] - Final Thoughts on UV Use in HVAC [10:01] - Future Discussion on HVAC vs. Building Envelope This Episode is Kindly Sponsored by: Master: https://www.master.ca/ Cintas: https://www.cintas.com/ Cool Air Products: https://www.coolairproducts.net/ property.com: https://mccreadie.property.com SupplyHouse: https://www.supplyhouse.com/tm Use promo code HKIA5 to get 5% off your first order at Supplyhouse! Follow the Guest John Ellis on: LinkedIn: https://www.linkedin.com/in/john-ellis-b13b0411/ Dust Free, LP: https://www.linkedin.com/company/dust-free-lp-/ The New Flat Rate, Inc.: https://www.linkedin.com/company/the-new-flat-rate-inc-/ Follow the Host: LinkedIn: https://www.linkedin.com/in/gary-mccreadie-38217a77/ Website: https://www.hvacknowitall.com Facebook: https://www.facebook.com/people/HVAC-Know-It-All-2/61569643061429/ Instagram: https://www.instagram.com/hvacknowitall1/

On this episode, Tudor sits down with Dr. Joanna Moncrieff to challenge the widely accepted narrative surrounding antidepressants. Together, they examine whether depression is truly caused by a serotonin imbalance and uncover the often-overlooked consequences of these medications. The discussion delves into the rising use of antidepressants—especially among teenagers—and the hidden costs, from emotional numbness to sexual dysfunction. They also question the pharmaceutical industry’s influence in shaping public perception and prescribing practices. The Tudor Dixon Podcast is part of the Clay Travis & Buck Sexton Podcast Network. For more visit TudorDixonPodcast.comSee omnystudio.com/listener for privacy information.

Joanna Moncrieff is a British psychiatrist and academic. She is Professor of Critical and Social Psychiatry at University College London and a member of the Critical Psychiatry Network. She is the author of The Myth of the Chemical Cure and The Bitterest Pills, which are considered central texts in the critical psychiatry movement. Moncrieff is critical of mainstream psychiatry's medical model of mental illness. Professor Moncrief's 2022 paper in molecular psychiatry didn't just make waves, it created a tsunami. Leading a systemic review of five decades of research, she and her team definitively demonstrated what no one had dared to state so clearly that there's no convincing evidence that depression is caused by a serotonin imbalance or any chemical imbalance at all. This paper became one of the most widely read scientific papers in modern history, ranking in the top 5 % of all research ever tracked. The world took notice because the world needed to know. Her groundbreaking new book, Chemically Imbalanced, The Making and Unmaking of the Serotonin Myth, meticulously documents how an entire medical narrative was constructed without scientific foundation marketed to billions and defended by institutions that should know better.https://joannamoncrieff.com/2022 paper in molecular psychiatry on Serotonin Chemically Imbalanced: The Making and Unmaking of the Serotonin Myth Dr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here

Meet Mina Hoshizawa, a dynamic in-house legal counsel who has built her career on adaptability and genuine connection. Now leading legal and compliance functions at Nihon Servier, she shares candid insights about unlearning perfectionism, embracing vulnerability as a leadership strength, and why being fluid like water has been her career superpower. If you are considering the transition to an in-house position or thinking you might skip the law firm experience and focus on in-house, this is the episode for you. If you enjoyed this episode and it inspired you in some way, we'd love to hear about it and know your biggest takeaway. Head over to Apple Podcasts to leave a review and we'd love it if you would leave us a message here!In this episode you'll hear:Why even practical motivations can lead to passionate careersThe art of "unlearning" from private practice what lawyers must focus on to win at in-house roles Her vulnerable leadership approach and what she often says to her teamPractical strategies for establishing legal functions from zero Where to look for opportunities if you intend to skip the law firm experienceAbout MinaMina Hoshizawa is Head of Legal and Compliance at Servier in Japan, sitting on the Leadership Team. Before joining Servier, she belonged to Bayer in Japan and served as Compliance Manager for the entire company and as Legal Manager for its Consumer Health Business and Crop Science Business. Mina is a qualified Japanese bengoshi (attorney), and before joining Bayer, she worked at Freshfields' Tokyo office. She is the leader of a working group of the Governance and Legal Committee of The European Federation of Pharmaceutical Industries and Associations (EFPIA). She was selected as LexisNexis® UNDER 40 2024, Japan Rising Star 2024 by GC Powerlist Legal 500, and became the first JILA In-house award winner in the Compliance category in Individual Awards 2023.In her free time Mina likes to play badminton with her daughter. Connect with Mina LinkedIn: https://www.linkedin.com/in/mina-hoshizawa-76ab01262/ Connect with Catherine LinkedIn https://www.linkedin.com/in/oconnellcatherine/Instagram: https://www.instagram.com/lawyeronair

As the world's second-largest producer of medication, India is facing increasing scrutiny over drug quality following deadly incidents involving Indian products. Is India's race to remain the "pharmacy of the world" coming at the cost of human lives? FRANCE 24's Khansa Juned and Lisa Gamonet report.

On episode 710 of the 40+ Fitness Podcast, we welcome back Dr. Ken Berry, a board-certified family physician, passionate health educator, and the author of Common Sense Labs: A Practical Guide to Decoding Your Blood Work and Taking Control of Your Health. Host Coach Allan and Dr. Berry dive deep into the often confusing world of blood work, covering why so many people are left in the dark by standard lab reports and what tests you should actually be asking your doctor for—especially if you're over 40. Dr. Berry shares down-to-earth advice from his book, explaining how simple lab markers can reveal the secrets of your metabolic health and empower you to take proactive steps toward better wellness. Together, they discuss the pitfalls of medication-first solutions, why so many doctors only skim the surface of your results, and what it really means to manage your health through lifestyle changes rather than prescriptions. Time Stamps: 04:34 Simplifying Medical Knowledge 09:02 Misdiagnosing Fibromyalgia Risks 10:55 Rethink Symptom-Driven Solutions 13:39 Comprehensive Thyroid Testing Guide 18:01 Traditional Diets Over Modern Foods 21:18 Low-Carb Diet: Traditional Diabetes Remedy 23:46 Insulin Test: Unrecognized by Doctors 29:07 Check Fasting Insulin Regularly 30:34 Reevaluating Prediabetes Diagnosis 36:10 LDL Particle Size Matters 38:07 Pharmaceutical Industry vs. Lifestyle Solutions 43:27 Fix Diet for Health Transformation 46:13 Fix Diet to Boost Fitness     https://DrBerry.com 

Dr. Chris Masterjohn is the host of the Mastering Nutrition Podcast and founder of Mitome, where he helps people optimize their mitochondrial health through advanced analysis. He received his PhD in Nutritional Sciences from the University of Connecticut, completed his postdoctoral research at the University of Illinois, and served as Assistant Professor at Brooklyn College before choosing to work independently - free from institutional constraints - in science research and education. His groundbreaking SSRI series on his substack hasn't just exposed the truth about these drugs. It's revealed that we've been looking at them completely wrong. Dr. McFillin and Dr. Masterjohn expose how these drugs act as mitochondrial toxins, disrupt cellular energy, and deplete serotonin. They also explore the consequences no one talks about: from prenatal exposure to why so many patients say they feel “dead inside.”Chris Masterjohn, PhD Website Dr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here

Sunil and James get together without their leader. They talk to each other as if they've just met at a Pharmaceutical Industry conference. Meanwhile, Chris is unspooling somewhere between Ireland and Scotland.  If you want to experience the full force of Rural Concerns Live, you can grab tickets to our Manchester show at Fairfield Social Club on 22nd November. If you have a Rural Concern you can send us an email to christopher@alovelytime.co.uk. We promise we'll be very kind! The best way to support this educational podcast is through Patreon. For less than a fiver you can get bonus episodes and access to our Discord community, The Creamery. Our artwork is by Poppy Hillstead, our music is by Sam O'Leary and our legal due diligence is by Cal Derrick, Entertainment Lawyer. Rural Concerns is edited by Joseph Burrows and produced by Egg Mountain for A Lovely Time Productions.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. HHS employees have accused RFK Jr. of spreading public mistrust against the CDC after a shooting at their headquarters. They have asked him to stop spreading health misinformation, especially about vaccines and infectious diseases. In other news, Johnson & Johnson has added $2 billion to their US manufacturing commitment amid Trump's tariff threats. Regeneron's Eylea HD decisions have been delayed, and Stealth Biotherapeutics' rejected Barth drug is returning to the FDA for review. Fedegari is now a one-stop solution provider for the pharmaceutical industry, offering highly customized solutions for sterile drug production. Additionally, the American pharma industry is facing challenges with tariffs and policy changes. Several upcoming webinars and job opportunities in the pharmaceutical industry are also highlighted in the newsletter.

When Brandon and Whitney Cawood's three-year-old son was expelled from daycare for aggressive behavior, they faced a crossroads that would change not only their lives but potentially millions of others. Rather than accepting the psychiatric diagnoses being pushed on them, they discovered something shocking: their son's severe behavioral issues weren't psychological at all—they were chemical reactions to synthetic food dyes hiding in his daily allergy medication and antibiotics.Within 48 hours of removing these petroleum-based chemicals from his diet, they met their real son for the first time. This revelation launched them on a journey that would lead to creating the documentary "To Dye For," building a community of nearly one million parents, and influencing legislation across multiple states.To Dye For Documentary Dr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here

What happens when you get laid off, divorced, and find yourself at rock bottom all at once? For serial entrepreneur and real estate powerhouse Betsy Pepine, it sparked a second act that changed everything. In this inspiring episode of the Second Act Success Career Podcast, host Shannon Russell chats with Betsy about how she went from being a single mom with two toddlers and no job to building a thriving real estate empire, including a brokerage, title company, mortgage business, property management firm, and a nonprofit.Betsy shares how losing control in her corporate job pushed her to build a life she could own...literally. She opens up about her “boxes” metaphor from her book Breaking Boxes, finding purpose through her nonprofit Pepine Gives, and her lessons from mentor Barbara Corcoran of Shark Tank.If you're a woman ready to quit your 9-5 and start a business, this episode is your sign to take control of your future.SHOW NOTES:https://secondactsuccess.co/208Connect with Betsy Pepine:https://www.pepinerealty.com/about/betsy-pepine/https://www.amazon.com/Breaking-Boxes-Dismantling-Metaphorical-That-ebook/dp/B0D6CM2JSL-------- You are listening to the Top 2% globally ranked podcast Second Act Success!READ Shannon's Book - Start Your Second Act: How to Change Careers, Launch a Business, and Create Your Best Life at https://startyoursecondact.com. Book a FREE Strategy Call with host and business coach Shannon Russell - https://www.calendly.com/second-act-success/coaching-strategyFREE Resourceshttps://secondactsuccess.co/resourcesLISTEN to the How To Quit Your Job and Start A Business Podcast! https://secondactsuccess.co/listenLET'S CONNECT!Instagram - https://instagram.com/secondactsuccessFacebook - https://www.facebook.com/secondactsuccess.coTikTok - https://www.tiktok.com/@secondactsuccessFREE Resources - https://secondactsuccess.co/resources REVIEW & SUBSCRIBE THE PODCAST!

The FDA held a panel discussion on antidepressants used during pregnancy. I was one of the expert presenters, and what I witnessed should alarm anyone who cares about honest medicine. In this episode, I break down the mainstream media response and what they kept out: SSRIs cross the placenta, change fetal brain development, and there is no proof they work at all- let alone prevent postpartum depression. You'll also hear why this is bigger than one drug class. It's about a system that medicalizes emotions and protects profit over people. If you want the truth the headlines won't give you, start here. Dr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here

In the fascinating world of Pharma, a visionary and pragmatic man, @Marc de Garidel, stands out. His journey began in a down-to-earth family, setting the stage for an extraordinary adventure.Careers are rarely planned, but his appetite for adventure emerged early:He launched Amgen in Europe.He developed Ipsen in the United States.These initial steps marked the commencement of an incredible journey in the pharmaceutical world, teaching him how Pharma truly operates, especially regarding access today.Then, he embarked on a more entrepreneurial path as the CEO of biotechs:Corvidia Therapeutics, sold to Novo Nordisk in August 2020.CinCor Pharma, sold to AstraZeneca in February 2023.Currently, he is the CEO of Abivax.This experience taught him that taking risks fuels innovation, and every failure is a step towards success.Today, as the CEO of Abivax, Marc shares his wealth of experience with the Pharma community. His story is an invitation to embrace the unknown, confront challenges with courage, and see every opportunity as a new adventure.Marc encourages bold minds to pursue their passions, dare to take risks, and view every obstacle as a step towards success.Marc is a passionate individual, a grounded soul unafraid to dream big for patients.His legacy serves as a timeless reminder that adventure, wisdom, and courage constitute a potent trio for those aspiring to push the boundaries of medical innovation.-Update since the recording of the episode:This interview took place in August 2023. In October, Abivax entered the Nasdaq. Despite a challenging stock market context, this is the largest IPO in the history of a French biotech.

For a captioned version or to access the transcript, please visit: https://www.pharmaron.com/knowledge-center/dmpk-insights-14-cns-modelling/In this podcast, Scott Summerfield and Professor Elizabeth de Lange discuss the evolution of CNS drug disposition models, highlighting the increasing sophistication of physiologically based pharmacokinetic (PBPK) models, such as LeiCNS-PK3.0. They discuss how these tools are enhancing our understanding of CNS drug distribution, predicting human pharmacokinetics, and supporting translational research across species.We will address the following questions:What scientific needs led to the development of early CNS drug models?How have tools like microdialysis and PBPK modeling shaped current CNS pharmacokinetic models?What role does the unbound drug concentration (Kpuu) play in predicting CNS drug effects?How do modern models like LeiCNS-PK3.0 integrate complex physiological and pharmacodynamic data?What are the future research directions and translational opportunities in CNS PK/PD modeling?Our Moderator:Scott Summerfield – Executive Director Metabolism at PharmaronScott Summerfield is the head of Metabolism, leading clinical and nonclinical radiolabeled ADME (Pharma and Environmental), in vivo support, imaging, as well as Discovery/Development and bioanalysis metabolite ID. Scott joined Pharmaron in 2022, having worked in the Pharmaceutical Industry for over 20 years, supporting both small and large molecule DMPK projects (Discovery and Development). He holds a PhD and a postdoctoral degree in protein mass spectrometry. He has published extensively in the areas of bioanalysis and the permeation of drugs across the blood-brain barrier.Our Speaker:Elizabeth de Lange – Professor Predictive Pharmacology at Leiden UniversityElizabeth de Lange is a Professor in Predictive Pharmacology and Principal Investigator at the Research Division of Systems Pharmacology and Pharmacy of the Leiden Academic Center for Drug Research (LACDR). With her team, she is helping to unravel the rate and extent of mechanisms that govern central nervous system (CNS) target site pharmacokinetics (PK) and related pharmacodynamics (PD), with a special emphasis on physiologically based (PB) translation between species and conditions. The ultimate aim is to have mathematical models that support CNS drug development (including reduction and replacement of nonclinical studies) and can predict the best possible treatment for CNS conditions in the individual patient (‘tailor-made'). Elizabeth has contributed over 160 peer-reviewed publications, delivered more than 170 invited lectures, and organized numerous conferences, symposia, courses, and workshops. She has had multiple leadership positions in scientific projects, also at LACDR, nationally with the NVF, in large international organizations (e.g., AAPS), and is currently the scientific coordinator of the EU consortium QSPainRelief. She has several roles on advisory board, provides both advice and consultancy, and alongside all of this Elizabeth contributes to education in the BioPharmaceutical Sciences bachelor's and master courses. Among other honors, Elizabeth received the AAPS Fellow Award (2013), an Honorary Doctorate in Pharmacy from Uppsala University (2020), and the prestigious Sheiner Lecture Lifetime Achievement Award from ISOP (2020).Stay tuned for more podcasts in our Pharmaron DMPK Insights Series!

Metis Consulting Services ML Bradley welcomed Kara Harrison to the "Queens of Quality" podcast, where Kara Harrison shared her extensive career journey in quality assurance, from the USDA and FDA to various consulting roles. Both Kara Harrison and Metis Consulting Services ML Bradley discussed the evolution of the consulting industry, emphasizing the importance of clear client scope and the challenges posed by clients who insist on incorrect approaches. A key talking point centered on the misconception among sponsors that outsourcing absolves them of responsibility, particularly concerning vendor qualification and oversight, which directly contradicts regulatory guidelines such as ICH E6R3.

Kate English, Chief economist with Deloitte

In this explosive and highly anticipated episode, Dr. Roger McFillin hosts Dr. Ragy Girgis, a Columbia University Professor of Psychiatry and researcher, for a no-holds-barred confrontation that exposes the shocking divisions tearing apart the mental health field. What begins as a conversation about mass violence research rapidly explodes into a devastating examination of psychiatric medicine's crumbling foundations, questionable effectiveness, and devastating potential harms. The two clash in fierce, unrelenting disagreements over fundamental issues including the validity of DSM diagnoses, the debunked "chemical imbalance" theory of depression, dangerous SSRI safety cover-ups and black box warnings, corrupted research quality and pharmaceutical industry manipulation, and the catastrophic crisis of psychiatric drug overprescription poisoning 1 in 4-5 Americans. Dr. Girgis desperately defends traditional academic psychiatry and current treatment approaches, while Dr. McFillin ruthlessly dismantles the entire paradigm, arguing that the current system is systematically creating chronic mental illness rather than healing it. Buckle up for this brutal intellectual warfare.___________________________________________________________________________________________________________________________________________________Throughout the interview, Dr. Girgis repeatedly stated that "the data is clear" while dismissing contradictory evidence that challenges his conclusions. For our listeners' benefit, I have compiled research and documentation that directly disputes several of Dr. Girgis's key claims.Serotonin Hypothesis of Depression1. The serotonin theory of depression: a systematic umbrella review of the evidence (Moncrieff et al.)Conclusions: "This review suggests that the huge research effort based on the serotonin hypothesis has NOT produced convincing evidence of a biochemical basis to depression. This is consistent with research on many other biological markers . We suggest it is time to acknowledge that the serotonin theory of depression is NOT empirically substantiated."2.What has serotonin to do with depression?Conclusions: "Simple biochemical theories that link low levels of serotonin with depressed mood are no longer tenable."3. Is the chemical imbalance an ‘urban legend'? An exploration of the status of the serotonin theory of depression in the scientific literatureViolence & Suicide Associated with SSRI's 1. Precursors to suicidality and violence on antidepressants: systematic review of trials in adult healthy volunteers2. Prescription Drugs Associated with Reports of Violence Towards Others3. Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family4. Lexapro Approved for Pediatric Use Despite the 6-Fold Increase in Suicide Risk5. McFillin Substack Review on Lexapro approved despite Suicide Risk6. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports7. Antidepressants Increase Suicide Attempts in Youth; No Preventative Effect8. Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk:9.  FDA Warning: Antidepressants increase the risk of suicidal thinking and behavior (suicidality) in children and adolescents10.  Suicide Mortality in the United States, 2001–2021 CDC documentation11. US suicide rate reaches highest point in more than 80 years: See what latest data shows12.  CNN article reporting Eli Lilly Internal Documents"An internal document purportedly from Eli Lilly and Co. made public Monday appears to show that the drug maker had data more than 15 years ago showing that patients on its antidepressant Prozac were far more likely to attempt suicide and show hostility than were patients on other antidepressants and that the company attempted to minimize public awareness of the side effects. The 1988 document indicated that 3.7 percent of patients attempted suicide while on the blockbuster drug, a rate more than 12 times that cited for any of four other commonly used antidepressants.In addition, the paper said that 1.6 percent of patients reported incidents of hostility -- more than double the rate reported by patients on any of four other commonly used antidepressants."Examples of Violence after Prescription in legal system (Sample)January 24, 2020 – Newcastle, South Dublin, Ireland: Deirdre Morley, 44, smothered and killed her two sons Conor, 9, and Darragh, 7, and her three-year-old daughter Carla McGinley in their family home. She had been taking antidepressants since October 2018 and was admitted to St. Patrick's Mental Health Services on July 6, 2019, but was discharged after a short period, but was put on a combination of two antidepressants and a sedativeMay 11, 2018 – Osmington, Western Australia: Peter Miles, 61, shot his 35-year-old daughter and four grandchildren, aged 8 through 13, while they slept in their beds, in a shed that had been converted to a second house on the property. He then turned the gun on his 58-year-old wife in the living room of their house, before placing a call to police alerting them to his crimes. When they arrived, Miles was also found dead from a gunshot wound. Miles had started taking antidepressant medication just weeks before.April 6, 2018 – Wadsworth, Ohio: Gavon Ramsay, 17, strangled his neighbor, 98-year-old Margaret Douglas in her own home. His parents blame his actions on his having been misprescribed Zoloft. After a report by his school principal that the teen was depressed and might harm himself, he “returned to therapy,” and after a recommendation by a psychologist, the family's pediatrician prescribed the antidepressant Zoloft. From January through March leading up to the incident, the dosages were increased. During this time, his mother said she observed her son's behavior change—becoming increasingly irritable and hostile and saying bizarre things.October 21, 2013 – Sparks, Nevada: 12-year-old Jose Reyes opened fire at Sparks Middle School, killing a teacher and wounding two classmates be...

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Merck recently made a significant move in the pharmaceutical industry by acquiring Verona for $10 billion, gaining access to the commercial COPD drug Ohtuvayre. This acquisition is viewed as a strategic decision to offset potential revenue loss when the patent for Keytruda expires. In other news, the Supreme Court has suspended an injunction preventing RFK Jr.'s HHS cuts. AstraZeneca also finalized a deal with JCR worth up to $825 million for gene therapy AAVs. Additionally, Trump has threatened 200% pharma tariffs, but has provided a one-year grace period for implementation. Drug developers are being advised to digitize their outsourcing path for optimal success in the industry. Furthermore, Novo Nordisk has terminated a deal with Hims & Hers, while Lilly has received an FDA label update for an Alzheimer's drug. Various developments in the longevity biotech space have also been highlighted. Stay tuned for more updates in the pharmaceutical industry.

Vietnam is emerging as one of the fastest-growing pharmaceutical markets in Southeast Asia. Rising healthcare demands, coupled with ongoing policy reforms, are creating exciting new opportunities. However, these developments also present significant challenges that businesses in the industry must navigate. So, what does it take to unlock the full potential of this dynamic and fast-evolving market?Our guest on this week's English edition of Vietnam Innovators is Ms. Katharina Geppert, Managing Director, MSD Vietnam, who has spent over four years living and working in Vietnam. Drawing from her leadership experience across multiple major markets, Ms. Geppert offers valuable insights into MSD's growth strategies, emerging trends in the pharmaceutical industry, and the collaborative opportunities between businesses and policymakers to build a more sustainable healthcare ecosystem for Vietnam.Thank you MSD Vietnam for accompanying Vietnam Innovators. MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, is one of the premier research-intensive biopharmaceutical companies in the world. With more than 130 years of experience, MSD is at the forefront of research, delivering innovative health solutions that advance the prevention and treatment of diseases in both people and animals. The company fosters a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, please visit www.msd.com and http://www.msd-vietnam.com; and connect with the MSD team on Twitter, LinkedIn, and YouTube...—Listen to this episode on ⁠YouTube⁠And explore many amazing articles about the pioneers at: ⁠⁠https://vietcetera.com/vn/bo-suu-tap/vietnam-innovator⁠Feel free to leave any questions or invitations for business cooperation at ⁠hello@⁠⁠vni-digest.com

Dr. Robert Sullivan, a 49-year-old anesthesiologist in peak physical condition, was featured in the Wall Street Journal for his aerial circus arts just months before getting his COVID vaccine. Within weeks of his second shot, he could barely walk upstairs without gasping for air. Diagnosed with pulmonary hypertension—a condition so rare it affects 1 in a million people and typically kills within 3-7 years—Dr. Sullivan found himself trapped between two devastating realities: his medical colleagues' dismissive silence and his own desperate search for answers. When the scientific method becomes subordinate to pharmaceutical profits and government narratives, medicine dies and propaganda in white coats takes its place. Dr. Sullivan and Dr. McFillin discuss the dangerous psychology of medical compliance and dissect how groupthink has weaponized modern healthcare. Dr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here

- World War III Imminent: Trump's Actions and Israel's Role (0:11) - Remote Viewing Experiments and Future Events (3:19) - Potential Nuclear Consequences and Global Impact (33:18) - Economic and Humanitarian Implications (48:40) - The Role of Satanism and Zionism (51:58) - Interview with Dr. Sherry Tenpenny on Vaccine Injuries (54:36) - Legal and Accountability Issues (58:54) - The Weaponization of Public Health (59:13) - The Role of the Media and Big Tech (59:29) - The Future of Vaccine Policy and Accountability (1:00:21) - Pharmaceutical Industry's Business Model (1:00:38) - AI in Medicine and Book Promotion (1:01:03) - Upcoming Events and Social Media Presence (1:27:20) - Health Ranger Store Product Promotion (1:28:23) - Final Remarks and Closing (1:30:55) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

Kinsella on Liberty Podcast: Episode 467. I was asked one Juani (@witheredsummer), an Argentinian Voluntarist, on Twitter and then later via email, to review his draft article "Ideas Are Free: A Case Against Intellectual Property" (text below) (I note that perhaps ironically, this title is almost identical to one of my own previous publications/speeches, Ideas are Free: The Case Against Intellectual Property: or, How Libertarians Went Wrong). I told him it was too long for me to fisk, got Grok to analyze it (see below), and told him to read up on some of my work and review the analysis, so that we could have a more productive conversation about it, and which I could also at least record for my podcast. This is our discussion. In the end, he didn't really have many questions and I think he just wanted to vent about how bad IP is and express frustration at out outrageous and harmful it is. And suggest some ways to get through to people and propose reforms. Things I already knew and have been writing about for 30 years. He basically identifies many problems with and absurdities with IP law ... which he's right about and which I've mentioned ... and comes up with some proposals for IP reform that would reduce its harm. Again, which he's right about and which I and others have also proposed, but also which are unlikely to be adopted by those infested with the IP mind-virus. Not really sure what the point of this was, but here it is FWIW. https://youtu.be/AS-8mFZGfnI GROK SHOWNOTES: [0:00-15:00] In this episode of the Stephan Kinsella podcast (KOL467), host Stephan Kinsella engages with Juani from Argentina to discuss intellectual property (IP) and its implications, particularly in the context of artificial intelligence (AI). Juani, a programmer and self-described libertarian, shares his consequentialist critique of IP, influenced by Kinsella's work and his own essay, "Ideas for Free: A Case Against Intellectual Property." The conversation begins with Juani outlining his concerns about IP's practical harms, such as its impact on innovation and culture, and transitions into a discussion about AI. They explore how AI's reliance on vast datasets, often containing copyrighted material, raises legal questions about copying, authorship, and derivative works. Kinsella highlights the tension between copyright law and AI development, noting that current laws could stifle AI's potential by limiting data access or imposing costly licensing requirements. [15:01-1:37:33] The discussion deepens into specific examples of IP's negative effects, including cultural erasure through Disney's sanitized retellings of historical figures like Pocahontas and Mulan, and the economic burdens of pharmaceutical patents, which restrict access to life-saving drugs in poorer nations. Juani argues that IP acts as a form of censorship and reinforces wealth disparities, citing cases like patent trolling and the high cost of educational materials in developing countries. Kinsella agrees, emphasizing that IP distorts markets and innovation, and suggests that copyright's harm to AI development may rival its threat to internet freedom. Toward the end, Juani proposes a reform to replace IP exclusivity with a decaying royalty system, which Kinsella views skeptically, arguing that entrenched IP proponents will resist any reduction in rights. The episode concludes with reflections on piracy, the success of platforms like Steam, and the cultural shift toward viewing copying as less harmful, signaling a potential change in public perception of IP.   Youtube Transcript and detailed Grok shownotes below. Related: KOL466 | On IP Reform and Improving IP law FDA and Patent Reform: A Modest Proposal “Absurd Arguments for IP” “The Patent, Copyright, Trademark, and Trade Secret Horror Files” Boldrin & Levine on Covid-19, Vaccines, the Pharmaceutical Industry, and Patents Patents and Pharmaceuticals

In this episode of Alter Everything, we chat with Patrick Leung, CTO of Faro Health, about the innovative ways his company is using generative AI to revolutionize the clinical trial process. They discuss handling unstructured data, insights generated by AI to optimize trials, and significant cost savings in the pharmaceutical space! Not sure what a clinical trial is? Fear not! Patrick explains the structure of clinical trials, Faro Health's AI-driven enhancements in medical writing, and the importance of data extraction and analysis.Panelists: Patrick Leung, Chief Technical Officer @ Faro Health - LinkedInMegan Bowers, Sr. Content Manager @ Alteryx - @MeganBowers, LinkedInShow notes: Faro HealthAlteryx's Generative AI for AnalyticsClinicaltrials.gov Interested in sharing your feedback with the Alter Everything team? Take our feedback survey here!This episode was produced by Megan Bowers, Mike Cusic, and Matt Rotundo. Special thanks to Andy Uttley for the theme music and Mike Cusic for the for our album artwork.

Season 10 is on the horizon, but before we release our first episode, why not tune in to some of Isabel and Jade's favourite moments from season 9?  From leadership insights from top CEOs to navigating setbacks in R&D, there's plenty to discover in this season's batch of GOLD Medal Moments.   As well as the EMJ GOLD team, you'll hear from four former guests:  Charl van Zyl, CEO, Lundbeck Pharmaceuticals  Dr Dennise Broderick, President and Managing Director, Galen Pharma  Rebecca Vermeulen, recipient of the Healthcare Businesswomen's Association (HBA) STAR award for 2025  Christoph von der Goltz, Global Head of Medicine Central Nervous System and Emerging Areas, Boehringer Ingelheim 

Analyzing Trump's plan to roll back soaring drug prices for Americans; Sports bras eliminate bounce but may take a toll on women's backs; RFK Jr. targets the chemicals in our food; Do Americans really eat more animal protein than any other of the world's nations? Causes and treatments for pulmonary hypertension.

How many times have you been told your heavy periods, low libido, or mood swings are “just part of being a woman”? Or handed birth control as the only option, without anyone actually explaining why your body feels off?If you're nodding along, this episode is a must-listen. Today, I'm joined by Dr. Jolene Brighten—a board-certified naturopathic endocrinologist, menopause specialist, and author of Beyond the Pill and Is This Normal?—and she's here to drop some serious truth bombs about women's health.We're breaking down the hormone myths that keep women confused and stuck, how to actually know if you have PCOS or endometriosis (even if you're on the pill), and why your sex drive, sleep, and strength training are all connected.Get ready for real talk, science-backed advice, and the permission you've been waiting for to finally understand (and trust) your body.​​Dr. Jolene Brighten is a board-certified naturopathic endocrinologist and best-selling author known for her expertise in women's health, hormones, and sexual wellness. Dr. Brighton is also the founder of Dr. Brighten Essentials.Trust me, you won't want to miss it! We Also Discuss:(00:31) The Truth About Women's Health – Dr. Jolene Brighten's No-BS Approach(13:13) Why Women's Health is Still Ignored: The Real Challenges(20:27) Endometriosis & PCOS: What You're Not Hearing from Doctors(29:52) Breaking the Silence: How to Normalize Women's Health Conversations(35:01) How Stress Kills Your Sex Drive: The Truth About Hormonal Balance(46:15) The Hidden Connection Between Hormones & Your Sexual Desire – Explained(58:02) Perimenopause Isn't the End: How to Thrive in Your 40s and Beyond(01:04:45) Eating, Sleeping, and Strength Training: The Key to Hormonal HarmonyThank You to Our Sponsors:Broads App – Get structured, progressive training and a powerhouse community to keep you strong, consistent, and unstoppable. Join at broads.app and use code PODCAST for 20% off your first month!Find more from Tara: Website: https://www.taralaferrara.com/Instagram: @taralaferrara @broads.podcast @broads.appYoutube: Tara LaFerraraTiktok: @taralaferraraFind more from Dr. Jolene BrightenWebsite: drbrighten.comInstagram: @drjolenebrightenTikTok: @drjolenebrightenYouTube: Dr. Jolene BrightenThe Perimenopause Weight Loss Action Plan: https://drbrighten.com/plan/

3 Big Stories: -Trump Administration has Success on International Stage -An American Pope Impossible No More, Chicago Native Cardinal Robert Prevost Elected and Announced as Pope Leo XIV -Trump Executive Order Demands Pharmaceutical Industry Slash Drug Prices

The Dublin-based biotech company Nuritas, which uses AI to identify supplements and new drugs by developing bioactive peptides, is changing the pharmaceutical industry.Their CEO, Nora Khaldi joins Kieran in Boston to discuss.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.President Donald Trump has issued an executive order to expedite the timeline for building new facilities in the US while increasing inspections on foreign plants. Despite a drop in venture capital fundraising in the first quarter of the year, large investments are still being made in the pharmaceutical industry. Companies like BMS are investing billions in US manufacturing despite potential tariffs. Vertex has seen success with their non-opioid pain drug launch and biopharma venture capital fundraising has declined, but median deal sizes remain high. Lotte Biologics offers specialized ADC manufacturing services in Syracuse, NY. Other news includes Lilly's ALS pipeline expansion, states suing to block HHS cuts, and layoffs at PTC despite a Phase II win. Thank you for tuning in to today's episode of Pharma and Biotech daily. Let's dive into the latest updates from the industry.

In this episode of Tickers, Dr. Matthew Preston & Dr. Thaon Simms analyze Indies Pharma (INDIES) and its potential to reach $5 per share!

Professor Jon Jureidini is a child psychiatrist who leads the Critical and Ethical Mental Health research group at Adelaide University in Australia. His forensic deconstruction of industry-sponsored clinical trials has exposed how pharmaceutical companies manipulate data, employ ghostwriters, and cultivate academic figureheads to create an illusion of scientific consensus around their products. Prof. Jureidini has revealed how medications prescribed to our most vulnerable populations—children and adolescents—gained approval based on studies that were fundamentally misrepresented in the scientific literature. In his groundbreaking book, 'The Illusion of Evidence-Based Medicine: Exposing the crisis of credibility in clinical research,' co-authored with Leemon McHenry, he systematically demonstrates how commercial interests have hijacked the evidence base that clinicians rely on, compromising patient care in the process. His work raises profound questions about the integrity of published research and challenges us to reconsider the foundations of modern medicine. Jureidini reveals shocking findings about the landmark 'Treatment of Adolescent Depression Study (TADS) study that's been used to justify prescribing antidepressants to teenagers—despite evidence showing a five-fold increase in suicidal events. With nearly 20% of adolescent girls now taking SSRIs, this conversation exposes the profit-driven deception that puts millions of developing brains at risk while pharmaceutical companies continue to thrive on what Jureidini calls "the illusion of evidence-based medicineChapters00:00 Introduction to the Crisis in Psychiatry02:20 The Illusion of Evidence-Based Medicine04:34 The TADS Study: A Closer Look10:47 Evaluating the TADS Study's Findings14:22 The Ethics of Informed Consent26:28 Risks and Alternatives in Treatment32:59 The Controversy of Antidepressant Prescriptions35:46 Ethical Concerns in Pharmaceutical Practices40:29 The Impact of Clinical Trials on Drug Approval47:08 Challenges in Psychiatric Research and Publication50:29 Restoring Trust in Scientific Integrity58:20 A Shift Towards Social Determinants of Mental Health RADICALLY GENUINE PODCASTDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here—-----------FREE DOWNLOAD! DISTRESS TOLERANCE SKILLS

In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman welcome Dr. Paul Offit to discuss the evolution of COVID-19 from pandemic to endemic status, the challenges of misinformation and public health messaging, and the importance of rebuilding trust in science. The scientists explore the challenges of effective public health communication amid widespread misinformation, examining how trust in scientific institutions has been affected. Dr. Offit shares insights on mRNA vaccine technology and addresses the evidence surrounding SARS-CoV-2's origins, emphasizing the scientific consensus supporting natural emergence rather than laboratory origin. The conversation also tackles the persistent vaccine-autism controversy, with Dr. Offit debunking common myths while providing context on autism research. Throughout the episode, the experts highlight the complex relationship between pharmaceutical development, public health, and the critical importance of evidence-based approaches to combat misinformation. (00:00) Intro (02:22) Understanding the Transition from Pandemic to Endemic (05:18) Misinformation and Public Health Messaging (10:21) Rebuilding Trust in Science (12:29) The Role of mRNA Technology in Vaccines (18:20) Comparing COVID-19 and Influenza (24:18) The Origins of SARS-CoV-2 (26:49) Investigating the Origins of SARS-CoV-2 (32:11) The Autism and Vaccine Controversy (37:25) Pharmaceutical Industry and Vaccine Trust (43:20) Natural Immunity vs. Vaccination (46:12) The Current State of Public Health and Vaccination https://www.paul-offit.com/ https://pauloffit.substack.com/ Dr. Offit's book: Tell Me When It's Over: An Insider's Guide to Deciphering Covid Myths and Navigating Our Post-Pandemic World https://amzn.to/3YSCDwq ----------------------------------------------------------------------------------------------------------------------- Interested in advertising with us? Please reach out to advertising@airwavemedia.com, with “Unbiased Science” in the subject line. PLEASE NOTE: The discussion and information provided in this podcast are for general educational, scientific, and informational purposes only and are not intended as, and should not be treated as, medical or other professional advice for any particular individual or individuals. Every person and medical issue is different, and diagnosis and treatment requires consideration of specific facts often unique to the individual. As such, the information contained in this podcast should not be used as a substitute for consultation with and/or treatment by a doctor or other medical professional. If you are experiencing any medical issue or have any medical concern, you should consult with a doctor or other medical professional. Further, due to the inherent limitations of a podcast such as this as well as ongoing scientific developments, we do not guarantee the completeness or accuracy of the information or analysis provided in this podcast, although, of course we always endeavor to provide comprehensive information and analysis. In no event may Unbiased Science or any of the participants in this podcast be held liable to the listener or anyone else for any decision allegedly made or action allegedly taken or not taken allegedly in reliance on the discussion or information in this podcast or for any damages allegedly resulting from such reliance. The information provided herein do not represent the views of our employers. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Tudor and Tim Murtaugh discuss the implications of the Biden pill penalty, a provision in the Inflation Reduction Act that negatively impacts the pharmaceutical industry and healthcare costs. They explore how this legislation discourages the development of cheaper, more effective medications, leading to increased healthcare costs and lost life years. The conversation also touches on the role of China in pharmaceutical development, the unintended consequences of legislation, and the importance of intellectual property laws in protecting creators. The Tudor Dixon Podcast is part of the CLay Travis & Buck Sexton Podcast Network. For more visit TudorDixonPodcast.comSee omnystudio.com/listener for privacy information.

Show Notes  Welcome friends to the Next Chapter with Charlie. Our fascinating guest today totally reinvented her life around 50 years old. From successful a successful life of 25 years in the Pharmaceutical Industry, Kavita realized her once fulfilling business life no longer offer the internal meaning she began longing for.  Instead of just living with dissatisfaction she searched and found a new way of life derived from the Japanese concept of Ikagi—"a way of being” that promotes meaning, purpose, and passion. Her story of discovery and reinvention guides all of us to reconsider what it means to live a most important life.  LINKS Please check out Kavita's website HERE.  You can find Kavita's podcast The Midlife Reinvention Podcast HERE.      

A panel discussion of a Presidential Advisory from the American Heart Association that outlines the importance of funding for scientific research and the need for a robust National Institutes of Health. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington INCLUDE URLS and full titles for some of the pertinent studies cited. You may also like: Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association https://doi.org/10.1161/cir.0000000000001319 The Role of Public-Sector Research in the Discovery of Drugs and Vaccines." https://www.nejm.org/doi/full/10.1056/NEJMsa1008268 Comparison of Research Spending on New Drug Approvals by the National Institutes of Health vs the Pharmaceutical Industry, 2010-2019 https://pubmed.ncbi.nlm.nih.gov/37115539/ Hear John Mandrola, MD's summary and perspective on the top cardiology news each week on This Week in Cardiology https://www.medscape.com/twic Questions or feedback, please contact news@medscape.net

Dr. Hoffmabn continues his conversation with investigative reporter Gardiner Harris, author of “No More Tears: The Dark Secrets of Johnson and Johnson.” 

Former pharma reporter for the New York Times and the Wall Street Journal, investigative reporter Gardiner Harris, discusses his new book “No More Tears: The Dark Secrets of Johnson and Johnson.” It details the unethical practices and numerous scandals that have plagued Johnson & Johnson over the decades, including the asbestos contamination in baby powder, the misuse of the antipsychotic drug Risperdal, the dangerous outcomes of vaginal mesh implants, and the controversial development and deployment of their COVID-19 vaccine. Harris provides a comprehensive overview of the corporate malfeasance within the pharmaceutical giant, shedding light on the regulatory failures and systemic corruption that have allowed these issues to persist.

Incyte Corporation v. Sun Pharmaceutical Industries, Ltd.

In this episode, Tudor interviews investigative journalist Gardiner Harris about his new book, 'No More Tears: The Dark Secrets of Johnson & Johnson.' The conversation delves into the shocking revelations about the pharmaceutical giant's unethical practices, including the marketing of harmful products, the manipulation of regulatory agencies, and the impact of their actions on public health. Harris shares insights from his five-year investigation, highlighting the need for accountability in the healthcare industry and the importance of informed consumer choices. The Tudor Dixon Podcast is part of the Clay Travis & Buck Sexton Podcast Network. For more visit TudorDixonPodcast.com Follow Gardiner Harris on X Buy No More Tears: The Dark Secrets of Johnson & Johnson HERE #Johnson & #Johnson #healthcare #pharmaceuticalindustry #ethics #investigativejournalism #publichealth #medicaldevices #COVID19 #marketing #regulationSee omnystudio.com/listener for privacy information.

In this episode of The Brand Called You, Dr. Tia Warrick, an AI and clinical research expert, shares insights on revolutionizing healthcare efficiency, bridging workforce gaps, and the future of pharmaceutical careers. Discover how AI is reshaping the industry and making clinical trials more effective.00:35- About Dr. Tia WarrickTia is a public health director, a clinical researcher, and an AI expert. She's the CEO of Lesous Consulting, and she's the author of a book titled Burst the Bubble: A Look Into Careers in the Pharmaceutical Industry.

Slovakia, dubbed Europe's Detroit, might be harshly hit by US tariffs. Economy Minister Denisa Saková has warned that Slovakia would definitely be “among the top three” most affected countries in the EU. Martin Šuster, member of the Council for Budget Responsibility, Alexander Matušek, President of the Association of the Automotive Industry of the Slovak Republic, and Roman Karlubík, President of the Association of the Chemical and Pharmaceutical Industry of the Slovak Republic, spoke about the possible impact on Slovakia. Culture tips for foreigners living in or visiting Slovakia invite to music, visual art and traditional Easter crafts.

Dr. Lufkin exposes the influence of the pharmaceutical industry on medical education and encourages listeners to take control of their health through informed choices about nutrition, exercise, sleep, and stress management. Learn why early health monitoring and metabolic awareness are key to preventing disease and living a longer, healthier life.In this episode of Amazing People Amazing Things, Dr. Robert Lufkin dives into the growing epidemic of chronic diseases and why Western medicine often falls short in addressing them.visit: www.RobertLufkinMD.comvisit: www.AmazingPeopleAmazingThings.com

Laura Delano is the author of “Unshrunk: A Story of Psychiatric Treatment Resistance”. Her story serves as a powerful lesson, illuminating the all too familiar path toward iatrogenic harm that continues to affect patients within our mental healthcare system. She is the Executive Director of Inner Compass Initiative, a charitable organization that she founded to help people make more informed choices about psychiatric diagnoses, drugs, and drug withdrawal. She is a leading voice in the international movement of people who've left behind the medicalized & professionalized mental health industry to build something different. Laura works with individuals and families around the world seeking guidance and support for psychiatric drug withdrawal and life post-psychiatry.Laura Delano Website Inner Compass Initiative 00:00 The Allure of Simple Explanations02:53 The Awakening of Laura Delano05:51 The Journey into Psychiatry08:47 The Impact of Diagnosis12:04 The Role of Family and Society15:00 The Medicalization of Mental Health18:08 The Influence of Pharmaceutical Industry21:00 The Consequences of Early Diagnosis24:04 The Quest for True Healing35:25 The Ethics of Experimental Drugs36:09 Understanding Perspectives in Psychiatry39:32 The Role of Responsibility in Prescribing43:16 Navigating Personal Identity and Mental Health47:45 Desperation and the Path to Psychiatry52:42 Cultural Reflections on Mental Health56:01 The Value of Pain and Suffering01:09:52 The Confusion of Psychiatric Treatment01:12:45 The Flaws in the Therapy Industry01:17:15 The Challenge of Questioning Authority01:19:46 The Trap of Psychiatric Diagnosis01:22:29 The Power Dynamics in Psychiatry01:26:46 The Disembodiment and Exploitation of Human Nature01:30:37 The Need for Medical Freedom01:34:39 The Importance of Compassion in Psychiatry01:39:30 Reclaiming Embodiment and True Nature01:41:54 Navigating the Path to Recovery RADICALLY GENUINE PODCASTDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here—-----------FREE DOWNLOAD! DISTRESS TOLERANCE SKILLS

In the latest episode of The Top Line, Chris Hayden of Fierce Pharma sits down with Mary Lou Glotzbach, senior manager of drug delivery partnerships at Grand River Aseptic Manufacturing (GRAM). They explore the evolving landscape of biologics, the increasing importance of cold chain management, and how contract development and manufacturing organizations (CDMOs) are adapting to industry shifts. Glotzbach highlights a growing trend in biotech: transitioning patient treatments from infusion centers to home delivery. This shift demands innovative drug delivery solutions, including wearable devices and auto-injectors, capable of handling high-viscosity biologics. She also emphasizes the industry's push for smaller batch sizes due to the high cost and complexity of producing biologics, which challenges traditional manufacturing processes. Another key discussion point is the rising demand for transparency and early collaboration between pharmaceutical companies, CDMOs, and device manufacturers. Glotzbach notes that CDMOs are now being brought into the development process earlier than ever, allowing for better alignment on formulation, container design, and regulatory compliance. The conversation also touches on Annex 1 compliance and the need for standardization in primary containers like syringes and cartridges. Glotzbach envisions a future where standardized components streamline production, making drug development more efficient. For anyone interested in the intersection of biologics, manufacturing, and drug delivery innovation, this episode offers valuable insights into how GRAM is helping shape the future of the industry. Tune in to learn more about the latest advancements and challenges in aseptic manufacturing.See omnystudio.com/listener for privacy information.

How is Trump's executive order redefining the language permissible in scientific research, and what does it mean for academic freedom? Today, we examine the complexities surrounding scientific research under shifting political landscapes with Ivan Oransky, a seasoned medical journalist and co-founder of Retraction Watch. Oransky discusses the implications of President Trump's executive orders and how it has sent ripples throughout the scientific community, causing researchers to reconsider their work amidst existential uncertainties. Oransky explores the nuanced relationship between government funding and scientific inquiry. This episode unpacks the historical precedents of government involvement in research, tracing back to the 1940s, and examines the mounting challenges faced by scientists under the recent policy changes. Oransky provides a critical analysis of how such directives potentially stifle open inquiry and drive talented researchers away, ultimately impacting the future landscape of scientific discovery. In This Episode:Implications of Trump's executive orders on scientific researchHistorical context of government funding in scientific researchThe impact of political climates on scientific inquiry and transparencyChallenges of anticipatory obedience within research communitiesIvan Oransky's insights on sustaining open and rigorous scientific dialogue About Ivan:Ivan Oransky, MD, is the co-founder of Retraction Watch, the Editor in Chief of The Transmitter, and a Distinguished Journalist in Residence at New York University's Carter Journalism Institute, where he teaches medical journalism. He has held leadership positions at Medscape, MedPage Today, Reuters Health, Scientific American, and The Scientist. A former president of the Association of Health Care Journalists from 2017 to 2021, Oransky earned his bachelor's degree from Harvard and an MD from NYU School of Medicine. His contributions to biomedical communication have earned him accolades, including the John P. McGovern Award and commendation from the John Maddox Prize judges for his work at Retraction Watch. Read HXA's newsletter Free the Inquiry: https://heterodoxacademy.substack.com/Follow Ivan on X: https://x.com/ivanoransky  Follow Heterodox Academy on:Twitter: https://bit.ly/3Fax5DyFacebook: https://bit.ly/3PMYxfwLinkedIn: https://bit.ly/48IYeuJInstagram: https://bit.ly/46HKfUgSubstack: https://bit.ly/48IhjNF

A Super Bowl commercial for weight loss drugs causes an uproar; Adding a familiar amino acid to tuna reduces mercury content; Rethinking epidural shots for back pain; CV Sciences debuts innovative new CBD gummies, drinks. 

In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy. SOURCES:Ezekiel Emanuel, vice provost for Global Initiatives, co-director of the Health Transformation Institute, and professor at the University of Pennsylvania Perelman School of Medicine. RESOURCES:"Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal," by Margot Sanger-Katz (The New York Times, 2024)."International Coverage of GLP-1 Receptor Agonists: A Review and Ethical Analysis of Discordant Approaches," by Johan L. Dellgren, and Govind Persad, and Ezekiel J. Emanuel (The Lancet, 2024).The Coming Wave: Technology, Power, and the Twenty-first Century's Greatest Dilemma, by Mustafa Suleyman (2023)."The Significance of Blockbusters in the Pharmaceutical Industry," by Alexander Schuhmacher, Markus Hinder, Nikolaj Boger, Dominik Hartl, and Oliver Gassmann (Nature Reviews Drug Discovery, 2022).Reinventing American Health Care: How the Affordable Care Act Will Improve Our Terribly Complex, Blatantly Unjust, Outrageously Expensive, Grossly Inefficient, Error Prone System, by Ezekiel J. Emanuel (2014)."Why I Hope to Die at 75," by Ezekiel J. Emanuel (The Atlantic, 2014)."Direct-to-Consumer Advertising of Pharmaceuticals," by Ziad F. Gellad and Kenneth W. Lyles (The American Journal of Medicine, 2014).Brothers Emanuel: A Memoir of an American Family, by Ezekiel J. Emanuel (2013)."Bounds in Competing Risks Models and the War on Cancer," by Bo E. Honoré and Adriana Lleras-Muney (Econometrica, 2006). EXTRAS:"How to Fix Medical Research," by People I (Mostly) Admire (2024)."The Suddenly Diplomatic Rahm Emanuel," by Freakonomics Radio (2023)."Ari Emanuel Is Never Indifferent," by Freakonomics Radio (2023)."Who Pays for Multimillion-Dollar Miracle Cures?" by Freakonomics, M.D. (2023)."Who Gets the Ventilator?" by Freakonomics Radio (2020).

Ever stop to think about the real cost of our modern lifestyle? Chronic illness, infertility, rising mental health challenges—they're not accidents. They're symptoms of systems designed to prioritize profit over people and the planet. From ultra-processed foods to toxic farming practices, we're trapped in a cycle that's stealing our vitality. In this episode of Super Life, I sit down with Dr. Zach Bush, a pioneer in regenerative health and farming, to pull back the curtain on how we got here—and how we can change. We're diving into the hidden dangers of our food systems, the power of reconnecting with nature, and practical steps you can take to restore balance to your life (and the planet). Dr. Zach Bush is a triple-board-certified physician specializing in internal medicine and endocrinology, and a globally recognized leader in microbiome research. He's also the founder of Farmer's Footprint, helping farmers transition to regenerative practices that heal our soil and our health. We Also Discuss:    (00:04) Confronting Our Failing Food System (10:00) The Shift: Herbal Medicine to Small Molecules (18:32) Pharmaceuticals, Biodiversity, and the Cost of Progress (46:21) Gender, Infertility, and the Fall of Empires (52:17) Reclaiming Natural Abundance (01:05:40) Humanity's Potential for Transformation   Don't forget… You can order now by heading to darinolien.com/fatal-conveniences-book or order now on Amazon.   Thank You to Our Sponsors Fatty15 : Get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/DARIN and using code DARIN at checkout. Bite: Go to trybite.com/DARIN20 or use code DARIN20 for 20% off your first order. Vivo Barefoot: Get 20% off your first Vivobarefoot order with DARIN20 at www.vivobarefoot.com Keywords: Food System, Healthcare System, Sustainability, Chronic Diseases, Mental Health, Regenerative Farming, Nature's Wisdom, Pharmaceutical Industry, Biodiversity, Virome, Genetic Adaptation, Monoculture, Environmental Change, Generational Trauma, Fertility Crisis, Gender Identity, Economic Empires, Natural Abundance, Human Potential, Transformation, Ancestral Trauma, Personal Growth Find more from Darin: Website: https://darinolien.com/ Instagram: @Darinolien Book: darinolien.com/fatal-conveniences-book/ Down to Earth: darinolien.com/down-to-earth/ Find more from Zach Bush: Website: https://zachbushmd.com/ Instagram: https://www.instagram.com/zachbushmd/